| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $796.4M | +8.7% |
| Cost of Revenue | $222.1M | +23.8% |
| Gross Profit | $574.3M | +3.9% |
| R&D Expense | $92.0M | +0.8% |
| SG&A Expense | $136.7M | +29.1% |
| Operating Income | $24.0M | -29.4% |
| Pre-tax Income | $48.3M | -20.2% |
| Income Tax | -$73.3M | -904.0% |
| Net Income | $121.6M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $145.3M | -11.4% |
| Current Assets | $854.1M | -14.7% |
| Total Assets | $1.18B | -3.2% |
| Current Liabilities | $517.6M | +1.9% |
| Total Liabilities | $572.1M | +5.3% |
| Stockholders' Equity | $612.1M | -10.0% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $77.6M | +8.6% |
| Capital Expenditures | $5.8M | -32.1% |
| Investing Cash Flow | $154.1M | +239.4% |
| Financing Cash Flow | -$248.2M | -1130.3% |
| Free Cash Flow | $71.8M | +14.1% |
| +136.6% |
| EPS (Basic) | $0.47 | +147.4% |
| EPS (Diluted) | $0.44 | +144.4% |